Literature DB >> 21941949

Correlation of sputum smear status with CD4 count in cases of pulmonary tuberculosis and HIV co-infected patients--a hospital based study in a rural area of Central India.

Sameer Singhal1, S N Mahajan, S K Diwan, Abhay Gaidhane, Z S Quazi.   

Abstract

BACKGROUND: In HIV-infected patients, PTB (Pulmonary Tuberculosis) is still the commonest form of TB. The most cost-effective method of detecting TB cases among PTB suspects in high-prevalence countries is by sputum smear microscopy. World Health Organisation (WHO) states that sputum positivity decreases accompanying with atypical chest x-ray findings as CD4 count decreases. This expectation that infection with HIV would reduce the sensitivity of acid-fast smears, due to a decreased frequency of cavitary pulmonary MTB, has not been substantiated in a few studies done in the past. This study was undertaken to see the correlation of sputum smear status with CD4 count in cases of Pulmonary Tuberculosis HIV coinfected patients in our institute, being a tertiary referral centre.
METHODOLOGY: In our hospital based cross-sectional study, 98 patients having PTB-HIV co-infection were followed and acid fast smear positivity status was assessed in correlation with chest radiograph and CD4 count.
RESULTS: Acid-fast smear positivity to negativity was almost 1:1 in CD4 count between 0-200 whereas it was 3:1 in cases of CD4 count above 200. There was significant difference (p value 0.013) in two groups with CD4 count cut-off value 200 which endorses the fact by WHO that sputum smear negativity increases with increase in degree of immunosupression.
CONCLUSION: Sputum examination remains an important diagnostic tool for pulmonary tuberculosis in immunocompromised host with CD4 count above 200 but there is an urgent need for better diagnostic methods in CD4 count below 200.

Entities:  

Mesh:

Year:  2011        PMID: 21941949

Source DB:  PubMed          Journal:  Indian J Tuberc        ISSN: 0019-5707


  4 in total

1.  Empirical tuberculosis therapy versus isoniazid in adult outpatients with advanced HIV initiating antiretroviral therapy (REMEMBER): a multicountry open-label randomised controlled trial.

Authors:  Mina C Hosseinipour; Gregory P Bisson; Sachiko Miyahara; Xin Sun; Agnes Moses; Cynthia Riviere; Fredrick K Kirui; Sharlaa Badal-Faesen; David Lagat; Mulinda Nyirenda; Kogieleum Naidoo; James Hakim; Peter Mugyenyi; German Henostroza; Paul D Leger; Javier R Lama; Lerato Mohapi; Jorge Alave; Vidya Mave; Valdilea G Veloso; Sandy Pillay; Nagalingeswaran Kumarasamy; Jing Bao; Evelyn Hogg; Lynne Jones; Andrew Zolopa; Johnstone Kumwenda; Amita Gupta
Journal:  Lancet       Date:  2016-03-19       Impact factor: 79.321

2.  Clinical Correlates and Drug Resistance in HIV-Infected and -Uninfected Pulmonary Tuberculosis Patients in South India.

Authors:  Chandy Sara; Heylen Elsa; Mishra Baijayanti; Ekstrand Maria Lennartsdotter
Journal:  World J AIDS       Date:  2016-09-09

3.  Quantification of Mycobacterium tuberculosis and Mycobacterium avium complex in human immunodeficiency virus-infected individuals with and without tuberculosis.

Authors:  Yashovardhan Naishadham; Vijay Kumar Jogishetty; Venkat Baghirath Pacha; Sudheer B Balla; B Hari Vinay; Parameshwar Naishadham
Journal:  J Oral Maxillofac Pathol       Date:  2019 May-Aug

4.  Survival among patients with HIV infection and smear-negative pulmonary tuberculosis - United States, 1993-2006.

Authors:  J Sean Cavanaugh; N Sarita Shah; Kevin P Cain; Carla A Winston
Journal:  PLoS One       Date:  2012-10-23       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.